v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 265,705 $ 248,491
Marketable securities, current 50,442 73,909
Accounts receivable, net of allowance for doubtful accounts of $1,244 and $1,101 as of March 31, 2024 and December 31, 2023, respectively 36,066 29,496
Prepaid expenses and other current assets 18,671 16,624
Deferred commissions, current 13,190 11,444
Total current assets 384,074 379,964
Property and equipment, net 10,871 10,068
Intangible assets, net 295 609
Goodwill 4,073 4,073
Restricted cash, noncurrent 872 869
Deferred commissions, noncurrent 25,071 26,942
Operating lease right-of-use assets 5,939 6,856
Other noncurrent assets 6,716 4,303
Total assets 437,911 433,684
Current liabilities:    
Accounts payable 14,573 3,063
Accrued expenses 26,228 26,657
Deferred revenue 102,774 102,573
Total current liabilities 143,575 132,293
Operating lease liabilities, noncurrent 2,536 3,604
Noncurrent liabilities 2,590 3,034
Total liabilities 148,701 138,931
Commitments and contingencies (Note 8)
Stockholders' equity    
Preferred stock, $0.00001 par value per share; 20,000 shares authorized as of March 31, 2024 and December 31, 2023; zero shares issued and outstanding as of March 31, 2024 and December 31, 2023 0 0
Additional paid-in capital 674,313 658,463
Accumulated other comprehensive loss (114) (181)
Accumulated deficit (384,990) (363,530)
Total stockholders' equity 289,210 294,753
Total liabilities and stockholders' equity 437,911 433,684
Class A Common Stock    
Stockholders' equity    
Common Stock Value 1 1
Class B Common Stock    
Stockholders' equity    
Common Stock Value $ 0 $ 0